PD-L1 expression was significantly more frequent in immune cells compared to tumor cells (p < 0.001) with an IC of at least 1% in one third of all cases (33.3%), while an IC above 10% and 25% was noted in 15% and 3% of the cases, respectively. This evidence concerns the gene CD274 and neoplasm.